Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2072studies shown
Showing 157-168 of 2,072
Device study icon
RecruitingNCT05276050

Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.

In Houston
SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 22 Years to 65 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT07378150

Clay Therapy in Schizophrenia Patients

This study is recruiting. It focuses on schizophrenia and currently lists participation information in Turkey.

In Kütahya
SchizophreniaBehavioralOver 18 Years
Countries
Turkey
Sponsor
Kutahya Health Sciences University
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT05656469

Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders

This study is recruiting. It focuses on anxiety and currently lists participation information in Germany, the Netherlands, Romania, Serbia, Spain, the United Kingdom, and the United States.

Multiple locations, including Syracuse
Anxiety, SchizophreniaBehavioralFrom 16 Years to 70 Years
Countries
United States, United Kingdom, Germany, ...
Sponsor
Parnassia Groep
Condition
Anxiety, Schizophrenia
Drug study icon
RecruitingNCT05824728

AGB101 for Schizophrenia

This study is recruiting in the United States. It is testing AGB101 for Schizophrenia.

In Baltimore
SchizophreniaDrugFrom 40 Years to 85 Years
Countries
United States
Sponsor
Johns Hopkins University
Condition
Schizophrenia
Drug study icon
RecruitingNCT04580134

CLOZAPINE Response in Biotype-1

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.

Multiple locations, including Hartford
Schizophrenia, BipolarityDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Schizophrenia, Bipolarity
Schizophrenia | Clinical Trials | HopeStage Research